PreComb

Oncosyne

This company develops patient-derived tumoroid drug screening platforms for pharmaceutical firms and oncologists to improve drug discovery and personalised cancer treatment.

Pear Bio

The company develops a precision medicine platform using microfluidic chips and computer vision to predict cancer treatment efficacy for oncologists and pharmaceutical researchers.

OncoPrecision

The company develops patient-derived micro-avatar models and therapeutic antibodies to provide oncology drug discovery and precision medicine services for pharmaceutical partners and clinicians.

Known Medicine

This company develops a platform using 3D cell culture and artificial intelligence to predict drug responses for oncologists and biopharmaceutical developers.

Organo-ID

The company develops 3D organoid models and drug response tests for cancer patients and pharmaceutical researchers to improve personalised medicine and treatment efficacy.

Orakl Oncology

This company develops a predictive platform using patient tumor avatars and data to help pharmaceutical firms accelerate and de-risk cancer drug development.

Astron Health

This company develops a precision oncology platform that provides molecular data analysis and personalised treatment reports for cancer patients and their clinicians.

Xilis

Xilis develops miniature patient-derived tumour models for precision oncology and drug discovery, serving clinicians and pharmaceutical companies.